Charles Schwab Investment Management »

Neurogene shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $519k 30k 17.33
2025-06-30 $448k 30k 14.95
2025-03-31 $398k 34k 11.71
2024-12-31 $693k 30k 22.86
2024-09-30 $1.3M 30k 41.96
2024-06-30 $1.1M 30k 36.39
2024-03-31 $267k 5.2k 50.90